Bristol-Myers shares fall 10% after cancer treatment disappoints

Facebook
ВКонтакте
share_fav

Shares of Bristol-Myers Squibb fell 9 percent, after the Opdivo trial result did not meet expectations.

посмотреть на CNBC: Top News